Wataya-Kaneda M - Search Results

1

Diagnostic flow analysis of tuberous sclerosis complex in Japan: a retrospective claims database study.

Okanishi T, Fujimori I, Yamada M, Tajima T, Wataya-Kaneda M, Seyama K, Hatano T. Okanishi T, et al. Among authors: wataya kaneda m. Orphanet J Rare Dis. 2024 Dec 1;19(1):451. doi: 10.1186/s13023-024-03460-y. Orphanet J Rare Dis. 2024. PMID: 39617898 Free PMC article.

2

A case of tuberous sclerosis with a giant angiofibroma.

Wataya-Kaneda M, Yano K, Hosokawa K, Yoshikawa K. Wataya-Kaneda M, et al. J Dermatol. 1997 Feb;24(2):132-4. doi: 10.1111/j.1346-8138.1997.tb02758.x. J Dermatol. 1997. PMID: 9065711

3

Analysis of all exons of TSC1 and TSC2 genes for germline mutations in Japanese patients with tuberous sclerosis: report of 10 mutations.

Yamashita Y, Ono J, Okada S, Wataya-Kaneda M, Yoshikawa K, Nishizawa M, Hirayama Y, Kobayashi E, Seyama K, Hino O. Yamashita Y, et al. Am J Med Genet. 2000 Jan 17;90(2):123-6. Am J Med Genet. 2000. PMID: 10607950

4

Cells derived from tuberous sclerosis show a prolonged S phase of the cell cycle and increased apoptosis.

Wataya-Kaneda M, Kaneda Y, Hino O, Adachi H, Hirayama Y, Seyama K, Satou T, Yoshikawa K. Wataya-Kaneda M, et al. Arch Dermatol Res. 2001 Sep;293(9):460-9. doi: 10.1007/s004030100259. Arch Dermatol Res. 2001. PMID: 11758789

5

Trends in the prevalence of tuberous sclerosis complex manifestations: an epidemiological study of 166 Japanese patients.

Wataya-Kaneda M, Tanaka M, Hamasaki T, Katayama I. Wataya-Kaneda M, et al. PLoS One. 2013 May 17;8(5):e63910. doi: 10.1371/journal.pone.0063910. Print 2013. PLoS One. 2013. PMID: 23691114 Free PMC article.

6

Clinical and Histologic Analysis of the Efficacy of Topical Rapamycin Therapy Against Hypomelanotic Macules in Tuberous Sclerosis Complex.

Wataya-Kaneda M, Tanaka M, Yang L, Yang F, Tsuruta D, Nakamura A, Matsumoto S, Hamasaki T, Tanemura A, Katayama I. Wataya-Kaneda M, et al. JAMA Dermatol. 2015 Jul;151(7):722-30. doi: 10.1001/jamadermatol.2014.4298. JAMA Dermatol. 2015. PMID: 25692384 Clinical Trial.

7

Lymphangioleiomyomatosis and multifocal micronodular pneumocyte hyperplasia in Japanese patients with tuberous sclerosis complex.

Tanaka M, Hirata H, Wataya-Kaneda M, Yoshida M, Katayama I. Tanaka M, et al. Respir Investig. 2016 Jan;54(1):8-13. doi: 10.1016/j.resinv.2015.06.003. Epub 2015 Oct 29. Respir Investig. 2016. PMID: 26718139

8

Efficacy and Safety of Topical Sirolimus Therapy for Facial Angiofibromas in the Tuberous Sclerosis Complex : A Randomized Clinical Trial.

Wataya-Kaneda M, Nakamura A, Tanaka M, Hayashi M, Matsumoto S, Yamamoto K, Katayama I. Wataya-Kaneda M, et al. JAMA Dermatol. 2017 Jan 1;153(1):39-48. doi: 10.1001/jamadermatol.2016.3545. JAMA Dermatol. 2017. PMID: 27837201 Clinical Trial.

9

Tuberous sclerosis complex: Recent advances in manifestations and therapy.

Wataya-Kaneda M, Uemura M, Fujita K, Hirata H, Osuga K, Kagitani-Shimono K, Nonomura N; Tuberous Sclerosis Complex Board of Osaka University Hospital. Wataya-Kaneda M, et al. Int J Urol. 2017 Sep;24(9):681-691. doi: 10.1111/iju.13390. Epub 2017 Jul 1. Int J Urol. 2017. PMID: 28667702 Review.

10

Sirolimus Gel Treatment vs Placebo for Facial Angiofibromas in Patients With Tuberous Sclerosis Complex: A Randomized Clinical Trial.

Wataya-Kaneda M, Ohno Y, Fujita Y, Yokozeki H, Niizeki H, Ogai M, Fukai K, Nagai H, Yoshida Y, Hamada I, Hio T, Shimizu K, Murota H. Wataya-Kaneda M, et al. JAMA Dermatol. 2018 Jul 1;154(7):781-788. doi: 10.1001/jamadermatol.2018.1408. JAMA Dermatol. 2018. PMID: 29800026 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

97 results

Search Page

Filters